Stock data
Castle Biosciences, Inc. (CSTL)
Castle Biosciences, Inc. (CSTL) reported revenue of US$344.23M and net income of -US$24.16M for fiscal 2025. The figures below come from the company's SEC filings.
Annual results
Data as of 2025-12-31
| Fiscal year | Revenue | Gross profit | Operating income | Net income | Diluted EPS |
|---|---|---|---|---|---|
| 2025 | US$344.23M | — | -US$42.81M | -US$24.16M | — |
| 2024 | US$332.07M | — | US$8.67M | US$18.25M | — |
| 2023 | US$219.79M | — | -US$67.98M | -US$57.47M | — |
| 2022 | US$137.04M | — | -US$72.86M | -US$67.14M | — |
| 2021 | US$94.08M | — | -US$40.08M | -US$31.29M | — |
Quarterly results
Data as of 2026-06-30
| Quarter | Revenue | Net income | Diluted EPS |
|---|---|---|---|
| 2026-06-30 | US$103.55M | -US$2.06M | — |
| 2026-03-31 | US$83.68M | -US$14.52M | — |
| 2025-12-31 | US$87.01M | -US$2.33M | — |
| 2025-09-30 | US$83.04M | -US$0.50M | — |
| 2025-06-30 | US$86.19M | US$4.52M | — |
| 2025-03-31 | US$87.99M | -US$25.85M | — |
| 2024-12-31 | US$86.31M | US$9.59M | — |
| 2024-09-30 | US$85.78M | US$2.27M | — |
Sources
- Source: SEC EDGAR company facts
Charts, drawing tools, and the P/E calculator are in the app, free to use.